Search

Displaying results 1801 - 1810 of 1980 in total
  1. Drug

    Icenticaftor

    go.drugbank.com/drugs/DB21466
    Investigational

    The usage of the INN stem '-caftor' in the name indicates that Icenticaftor is a Cystic fibrosis transmembrane regulator (CFTR) protein modulator, corrector, and amplifier.

  2. Drug

    Rezivertinib

    go.drugbank.com/drugs/DB21471
    Investigational

    The usage of the INN stem '-ertinib' in the name indicates that Rezivertinib is a epidermal growth factor receptor (EGFR) inhibitor.

  3. Drug

    Tuxobertinib

    go.drugbank.com/drugs/DB21508
    Investigational

    The usage of the INN stem '-ertinib' in the name indicates that Tuxobertinib is a epidermal growth factor receptor (EGFR) inhibitor.

  4. Drug

    Linvencorvir

    go.drugbank.com/drugs/DB21544
    Investigational

    The usage of the INN stem '-corvir' in the name indicates that Linvencorvir is a core protein (Cp) inhibitor.

  5. Drug

    Fipravirimat

    go.drugbank.com/drugs/DB21578
    Investigational

    The usage of the INN stem '-virimat' in the name indicates that Fipravirimat is a antiviral, disruptor of viral maturation.

  6. Drug

    Opnurasib

    go.drugbank.com/drugs/DB21583
    Investigational

    The usage of the INN stem '-rasib' in the name indicates that Opnurasib is a Ras protein inhibitor.

  7. Drug

    Relutrigine

    go.drugbank.com/drugs/DB21614
    Investigational

    The usage of the INN stem '-trigine' in the name indicates that Relutrigine is a sodium channel blocker, signal transduction modulator.

  8. Drug

    Foselutoclax

    go.drugbank.com/drugs/DB21663
    Investigational

    The usage of the INN stem '-toclax' in the name indicates that Foselutoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor.

  9. Drug

    Oditrasertib

    go.drugbank.com/drugs/DB21526
    Investigational

    The usage of the INN stem '-sertib' in the name indicates that Oditrasertib is a serine/threonine kinase inhibitor.

  10. Drug

    Ruserontinib

    go.drugbank.com/drugs/DB21555
    Investigational

    The usage of the INN stem '-tinib' in the name indicates that Ruserontinib is a tyrosine kinase inhibitor.